Keros Therapeutics is a preclinical venture-funded private biotechnology company dedicated to the discovery and development of breakthrough therapeutics for neuromuscular diseases.


Our team is focused on small molecule and biologic approaches to treat neuromuscular diseases with high unmet medical need.